Table 2.
Physician reasons not to report adverse drug reactions (ADRs)
| Determinants | Frequency | Percentage |
|---|---|---|
| Attitudes relating to professional activity | 1 | 0.7% |
| Financial incentives | 0 | - |
| Litigation concerns | 0 | - |
| Ambition to publish | 1 | 0.7% |
| Factors associated with ADR-related knowledge and attitudes | 73 | 50% |
| Complacency (only safe medications are marketed) | 5 | 3.4% |
| Insecurity (determining whether or not a drug is responsible for a particular ADR) | 6 | 4.1% |
| Diffidence (fear of appearing ridiculous) | 5 | 3.4% |
| Indifference (contributing to the general advancement of medical knowledge/lack of understanding of the purpose of reporting) | 33 | 22.6% |
| Ignorance (only severe ADRs need to be reported) | 24 | 16.4% |
| Excuses made by professionals | 72 | 49.3% |
| Lack of time | 52 | 35.6% |
| Different care priorities | 5 | 3.4% |
| Difficulty in accessing report form | 3 | 2.1% |
| Reporting process as extremely bureaucratic and complex | 12 | 8.2% |
| Aversion to disclosing confidential information | 0 | - |
Physician reasons not to report adverse drug reactions to the Netherlands Pharmacovigilance left Lareb subdivided into known determinants influencing the adverse drug reaction (ADR) reporting rates in healthcare professionals.